Neuro-Peds T1D

The Neuro-Peds T1D Consortium seeks to establish a diverse longitudinal cohort of pediatric patients newly diagnosed with type 1 diabetes (T1D) and pediatric controls to: 1) better understand the impact of T1D on the developing brain, including neurocognitive and psychosocial functioning, 2) identify and evaluate potential risk and protective factors associated with T1D-related neurocognitive impact, and 3) assess potential associations between diabetes management technologies and neurocognitive functioning among children with T1D. 

This multi-institution clinical consortium will develop and implement a uniform protocol to investigate the neurocognitive impact of new onset type 1 diabetes (T1D) in pre-pubertal children. The Biostatistics Research Center provides scientific leadership for the consortium and consortium-wide infrastructure related to data management and sharing, study design and statistical analysis, and governance and coordination of consortium activities.

Funder: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.